Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries by Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A.-M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C.

Get full text

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments by Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J.-J, Nathan, P, Dummer, R, Forsea, A.-M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M, Garbe, C

Get full text

Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries by Kandolf‐Sekulovic, L., Peris, K., Stratigos, A., Hauschild, A., Forsea, A.‐M., Lebbe, C., Lallas, A., Grob, J.‐J., Harwood, C., Gogas, H., Rutkowski, P., Olah, J., Kelleners‐Smeets, N.W.J., Paoli, J., Dummer, R., Moreno‐Ramirez, D., Bastholt, L., Putnik, K., Karls, R., Hoeller, C., Vandersleyen, V., Vieira, R., Arenberger, P., Bylaite‐Buckinskiene, M., Ocvirk, J., Situm, M., Weinlich, G., Banjin, M., Todorovic, V., Ymeri, A., Zhukavets, A., Garbe, C.

Get full text

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results by Beslija, S, Banjin, M, Jungic, S, Obralic, N, Kecman-Malcic, G, Rakita, I, Salkic, B, Pasic, A, Tinjic, L, Ajanovic, E

Get full text

Combined radio-chemotherapy (CR) in advanced cervical cancer: a phase-II trial with cisplatin and bleomycin by Kantardzic, N., Beslija, S., Musanovic, M., Cardzic, A., Kazic, N., Mahic, N., Paraganlija, N., Lomigoric, J., Banjin, M.

Get full text